Literature DB >> 30547078

Drug-Drug Interaction Discovery: Kernel Learning from Heterogeneous Similarities.

Devendra Singh Dhami1, Gautam Kunapuli1, Mayukh Das1, David Page2, Sriraam Natarajan1,3.   

Abstract

We develop a pipeline to mine complex drug interactions by combining different similarities and interaction types (molecular, structural, phenotypic, genomic etc). Our goal is to learn an optimal kernel from these heterogeneous similarities in a supervised manner. We formulate an extensible framework that can easily integrate new interaction types into a rich model. The core of our pipeline features a novel kernel-learning approach that tunes the weights of the heterogeneous similarities, and fuses them into a Similarity-based Kernel for Identifying Drug-Drug interactions and Discovery, or SKID3. Experimental evaluation on the DrugBank database shows that SKID3 effectively combines similarities generated from chemical reaction pathways (which generally improve precision) and molecular and structural fingerprints (which generally improve recall) into a single kernel that gets the best of both worlds, and consequently demonstrates the best performance.

Entities:  

Keywords:  Drug-Drug interactions; Graph query; Kernel learning; Knowledge graph; Relational random walks; Similarity matrix

Year:  2018        PMID: 30547078      PMCID: PMC6289266          DOI: 10.1016/j.smhl.2018.07.007

Source DB:  PubMed          Journal:  Smart Health (Amst)        ISSN: 2352-6483


  22 in total

1.  Predicting adverse drug events from personal health messages.

Authors:  Brant W Chee; Richard Berlin; Bruce Schatz
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 3.  Similarity-based machine learning methods for predicting drug-target interactions: a brief review.

Authors:  Hao Ding; Ichigaku Takigawa; Hiroshi Mamitsuka; Shanfeng Zhu
Journal:  Brief Bioinform       Date:  2013-08-11       Impact factor: 11.622

4.  Using a shallow linguistic kernel for drug-drug interaction extraction.

Authors:  Isabel Segura-Bedmar; Paloma Martínez; Cesar de Pablo-Sánchez
Journal:  J Biomed Inform       Date:  2011-04-24       Impact factor: 6.317

5.  A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports.

Authors:  Nicholas P Tatonetti; Guy Haskin Fernald; Russ B Altman
Journal:  J Am Med Inform Assoc       Date:  2011-06-14       Impact factor: 4.497

6.  Similarity-based modeling in large-scale prediction of drug-drug interactions.

Authors:  Santiago Vilar; Eugenio Uriarte; Lourdes Santana; Tal Lorberbaum; George Hripcsak; Carol Friedman; Nicholas P Tatonetti
Journal:  Nat Protoc       Date:  2014-08-14       Impact factor: 13.491

7.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

Review 8.  What do drug transporters really do?

Authors:  Sanjay K Nigam
Journal:  Nat Rev Drug Discov       Date:  2014-12-05       Impact factor: 84.694

9.  Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).

Authors:  Anne T Nies; Ute Hofmann; Claudia Resch; Elke Schaeffeler; Maria Rius; Matthias Schwab
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

10.  Extraction of potential adverse drug events from medical case reports.

Authors:  Harsha Gurulingappa; Abdul Mateen-Rajput; Luca Toldo
Journal:  J Biomed Semantics       Date:  2012-12-20
View more
  2 in total

Review 1.  On the road to explainable AI in drug-drug interactions prediction: A systematic review.

Authors:  Thanh Hoa Vo; Ngan Thi Kim Nguyen; Quang Hien Kha; Nguyen Quoc Khanh Le
Journal:  Comput Struct Biotechnol J       Date:  2022-04-19       Impact factor: 6.155

2.  A novel kernel based approach to arbitrary length symbolic data with application to type 2 diabetes risk.

Authors:  Nnanyelugo Nwegbu; Santosh Tirunagari; David Windridge
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.